NDC 70022-010 - buprenorphine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70022-010
- Package NDCs from labels
- 70022-010-03, 70022-010-10
- Manufacturer
- PAYLESS COMPOUNDERS, LLC
- Effective date
- 2024-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| buprenorphine - PAYLESS COMPOUNDERS, LLC | PAYLESS COMPOUNDERS, LLC | 2024-12-11 | ANIMAL COMPOUNDED DRUG LABEL |
| buprenorphine - PAYLESS COMPOUNDERS, LLC | PAYLESS COMPOUNDERS, LLC | 2015-10-02 | ANIMAL COMPOUNDED DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70022-010-03 | buprenorphine | 30 mL in 1 BOTTLE, PLASTIC | SOLUTION | 30 | 10 | |
| 70022-010-10 | buprenorphine | 100 mL in 1 BOTTLE, PLASTIC | SOLUTION | 100 | 10 | |
| 70022-010-03 | buprenorphine | 30 mL in 1 BOTTLE, PLASTIC | SOLUTION | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70022-010 | BUPRENORPHINE INJECTION, SOLUTION BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC] | 10 | 2 package rows | 20241213_a1c1f498-e101-467f-b81c-1451c44e7a01.zip |
| 70022-010 | BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC] | 1 | 1 package rows | 20151002_8081ccb8-1b38-4673-a9dd-0fb18fa6038a.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | OJ245FE5EU 1Q73Q2JULR Z8IX2SC1OH A2I8C7HI9T |
| Ivy-Dry Super | BENZYL ALCOHOL, CAMPHOR, MENTHOL | Ivy-Dry, Inc. | 4792a667-2378-4b3d-968d-9efb1866792f | 2017-12-27 | Warnings | LKG8494WBH |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | LKG8494WBH |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.